-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: January 2013
A Big Year for Novel Drugs Approvals
What was your top Biopharma highlight for 2012? If it wasn’t the stellar move in the AMEX Biotech Index (up 42%), or the reauthorization of PDUFA, then perhaps it was the decade high for innovative drugs approvals. We would need to go back to the 1990s to find a year with as many FDA approvals for novel drugs as we had in 2012. Adding to the positive trend in numbers, up 29% from the robust Read More >
Poster Session at BIO’s World Congress Showcases Cutting Edge Research
BIO’s 10th Annual World Congress on Industrial Biotechnology taking place this June in Montreal will feature a poster session highlighting cutting edge research in industrial biotech. Professors, students, scientists and industry reps are all encouraged to submit posters detailing their research that could lead to the next big breakthrough. Numerous poster submissions have already come in and it’s looking to be a banner year in research. One poster describes a novel pretreatment process using oxalic acid Read More >
New Year, New Resolutions: Kickstart Your Career with the BIO International Convention
With 2012 behind us and 2013 well under way, now is the time to re-establish professional goals for a prosperous year. BIO’s events serve as a professional networker’s playground and our flagship event, the BIO International Convention is a little more than 100 days away. If your 2013 to-do list includes professional enrichment and business development, the BIO International Convention is the place to be in April. Here a few tips to help kick start Read More >
BIO’s South Dakota Affiliate Announces New Executive Director
The South Dakota Biotechnology Association has hired Joni Johnson, a renewable fuels industry expert, as the new executive director. Joni Johnson previously headed up operations for the bioethanol company Poet’s political action committee. Johnson also is a veteran of many state-wide political campaigns, and she plans to prioritize advocacy at the state and national level for the association’s membership. “They need to have a voice in critical decisions that impact this industry,” she said. “It’s Read More >
California Biomedical Companies Cite Lack Of Funding As Major Concern
As I have mentioned in past blog posts, the U.S. bioscience industry has demonstrated stability through turbulent economic times. While not immune from the recession, this industry generally fared much better than the overall economy and has remained a net a job generator. In April of 2012, the White House released the National Bioeconomy Blueprint noting that bioscience industries are “a large and rapidly growing segment of the world economy that provides substantial public benefit.” Read More >
